Abstract
This article explores the ways in which human dignity is used in debates about controversial biotechnologies, including biobanks, human gene patents, stem cell research and human cloning. Increasingly, human dignity is used as a form of general condemnation and as blanket justification for regulatory restraint. However, this use of human dignity marks a significant departure from the traditional, human-rights informed view of human dignity that has dominated bioethics debates for decades. In addition, on its own, it stands as dubious justification for policies that are aimed at constraining controversial biotechnologies.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Values and value conflicts in implementation and use of preconception expanded carrier screening - an expert interview study
BMC Medical Ethics Open Access 23 April 2019
-
Regulatory Fitness: Fintech, Funny Money, and Smart Contracts
European Business Organization Law Review Open Access 19 February 2019
-
The Old ‘New’ Dignitarianism
Res Publica Open Access 18 October 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Fukuyama, F. Our Posthuman Future (Profile Books, New York, 2002).
The President's Council on Bioethics. Human cloning and human dignity: an ethical inquiry. The President's Council on Bioethics web site [online], <http://www.bioethics.gov/reports/cloningreport/fullreport.html> (2002).
Caulfield, T. Human cloning laws, human dignity and the poverty of the policy making dialogue. BMC Med. Ethics 4, e3 (2003).
Verspieren, P. in The Discourse of Human Dignity (eds Ammicht-Quinn, R. et al.) 13–22 (SCM Press, London, 2003).
Brownsword, R. in Human Rights (ed. Brownsword, R.) 203–234 (Hart, Oxford, 2004).
Bush, G. W. President Bush calls on Senate to back human cloning ban; remarks by the President on human cloning legislation. The White House web site [online], <http://www.whitehouse.gov/news/releases/2002/04/20020410-4.html> (2002).
Macklin, R. Dignity is a useless concept. Br. Med. J. 327, 1419–1420 (2003).
Caulfield, T. & Chapman, A. Human dignity as a criterion for science policy. PLoS Med. 2, e244 (2005).
Brownsword, R. Stem cells and cloning: where the regulatory consensus fails. New Engl. Law Rev. 39, 535–571 (2005).
Beyleveld, D. & Brownsword, R. Human Dignity in Bioethics and Biolaw (Oxford Univ. Press, Oxford, 2001).
Brownsword, R. Three bioethical approaches: a triangle to be squared. The international conference on the patentability of biotechnology [online], <www.ipgenethics.org/conference/transcript/session3.doc> (2004).
Horton, R. Rediscovering human dignity. Lancet 364, 1081–1085 (2004).
Shannon, T. Grounding human dignity. Dialog 43, 113–117 (2004).
Shultziner, D. Human dignity — functions and meanings. Global Jurist Topics 3, 1–21 (2003).
Harris, J. & Sulston, J. Genetic equity. Nature Rev. Genet. 5, 796–800 (2004).
Arnason, G., Nordel, S. & Arnason, V. (eds) Blood and Data: Ethical, Legal and Social Aspects of Human Genetics Databases (Univ. Iceland Press and Centre for Ethics, Reykjavik, 2004).
Cambon-Thomsen, A. The social and ethical issues of post-genomic human biobanks. Nature Rev. Genet. 5, 866–873 (2004).
Austin, M. A., Harding, S. & McElroy, C. Genebanks: a comparison of eight proposed international genetic databases. Community Genet. 6, 37–45 (2003).
UNESCO. Draft Report on Collection, Treatment, Storage and Use of Genetic Data (UNESCO, Paris, 2001).
Gertz, R. An analysis of the Icelandic Supreme Court judgement on the Health Sector Database Act. SCRIPT-ed 1, 290–306 (2004).
World Health Organization. Genetic Databases: Assessing the Benefits and the Impact on Human and Patient Rights (World Health Organization, Geneva, 2003).
Medical Research Council of Canada et al. Tri-council policy statement: ethical conduct for research involving humans. Interagency Advisory Panel on Research Ethics web site [online], <http://www.pre.ethics.gc.ca/english/policystatement/policystatement.cfm> (1998; with 2000, 2002, 2005 ammendments).
World Medical Association. Declaration of Helsinki — Ethical Principles for Medical Research Involving Human Subjects (World Medical Association, Edinburgh, 2000).
Reibl v. Hughes, 114 DLR 3rd 1 Supreme Court of Canada (1980).
Australian Law Reform Commission. Genes and ingenuity: gene patenting and human health. ALRC Report 99 [online], <http://www.austlii.edu.au/au/other/alrc/publications/reports/99/> (2004).
Brownsword, R. The Relaxin opposition revisited. Jahrb. Recht Ethi k; Annu. Rev. Law Ethics 9, 3–19 (2001).
Dworkin, G. Should there be property rights in genes? Philos. Trans. R. Soc. Lond. B 352, 1077–1086 (1997).
Standing Committee on Health. Assisted reproduction: building families. House of Comons, Canada [online], <http://www.parl.gc.ca/InfoComDoc/37/1/HEAL/Studies/Reports/healrp01-e.htm> (2001).
UNESCO International Bioethics Committee. Universal Declaration on the Human Genome and Human Rights (UNESCO, Paris, 1997).
Dickenson, D. The new French resistance: commodi-fication rejected? Med. Law Int. 7, 41–63 (2005).
Gold, R. Owning our bodies: an examination of property law and biotechnology. San Diego Law Rev. 32, 1167–1247 (1995).
Howard Florey v. Relaxin, EPOR 541 (opposition division) (1995).
Resnik, D. B. DNA patents and human dignity. J. Law Med. Ethics 29, 152–165 (2001).
Beyleveld, D. & Brownsword, R. Human dignity, human rights, and human genetics. Mod. Law Rev. 61, 661–680 (1998).
Brown, B. The case for caution — being protective of human dignity in the face of corporate forces taking title to our DNA. J. Law Med. Ethics 29, 166–169 (2001).
Danish Council on Ethics. Patenting Human Genes and Stem Cells (Danish Council on Ethics, Copenhagen, 2004).
UNESCO International Bioethics Committee. International Declaration on Human Genetic Data (UNESCO, Paris, 2003).
Gilmour, J. 'Our' bodies: property rights in human tissue. Can. J. Law Soc. 8, 113–138 (1993).
Kieff, F. S. Perusing property rights in DNA. Adv. Genet. 50, 125–151; discussion 507–510 (2003).
Caulfield, T., Gold, E. R. & Cho, M. K. Patenting human genetic material: refocusing the debate. Nature Rev. Genet. 1, 227–231 (2000).
Beyleveld, D., Brownsword, R. & Llewelyn, M. in Pharmaceutical Medicine, Biotechnology and European Law (eds Goldberg, R. & Lonbay, J.) 157–181 (Cambridge Univ. Press, New York, 2000).
European Group on Ethics in Science and New Technologies. The Ethical Aspects of Patenting Inventions Involving Human Stem Cells: Opinion to the European Commission (European Group on Ethics in Science and New Technologies, Brussels, 2002).
Fifty-Ninth General Assembly. General Assembly adopts United Nations Declaration on Human Cloning by vote of 84–34–37. 82nd Meeting (AM) Press Release [online], <http://www.un.org/News/Press/docs/2005/ga10333.doc.htm> (2005).
Brownsword, R. in The Impact of Biotechnologies on Human Rights (ed. Francioni, F.) (Hart, Oxford, 2006).
Pattinson, S. D. & Caulfield, T. Variations and voids: the regulation of human cloning around the world. BMC Med. Ethics 5, e9 (2004).
Wijnberg, B. Intergovernmental activities in bioethics worldwide. 8th European Conference of National Ethics Committees [online], <http://www.coe.int/T/E/Legal_affairs/Legal_co-operation/Bioethics/COMETH/ACTES%208e%20COMETH.pdf>(2005).
Chadwick R. & Berg, K. Solidarity and equity: new ethical frameworks for genetic databases. Nature Rev. Genet. 2, 318–321 (2001).
Habermas, J. The Future of Human Nature (Polity Press, Malden, Massachusetts, 2003).
Brownsword, R. Regulating human genetics: new dilemmas for a new millennium. Med. Law Rev. 12, 14–39 (2004).
Acknowledgements
T.C. would like to thank M. Sharp for his insight and help, the anonymous reviewers for the useful comments and Genome Canada, the Stem Cell Network and the Alberta Heritage Foundation for Medical Research for funding support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
Rights and permissions
About this article
Cite this article
Caulfield, T., Brownsword, R. Human dignity: a guide to policy making in the biotechnology era?. Nat Rev Genet 7, 72–76 (2006). https://doi.org/10.1038/nrg1744
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrg1744
This article is cited by
-
Values and value conflicts in implementation and use of preconception expanded carrier screening - an expert interview study
BMC Medical Ethics (2019)
-
The Old ‘New’ Dignitarianism
Res Publica (2019)
-
Regulatory Fitness: Fintech, Funny Money, and Smart Contracts
European Business Organization Law Review (2019)
-
The biogenetical revolution of the Council of Europe - twenty years of the Convention on Human Rights and Biomedicine (Oviedo Convention)
Life Sciences, Society and Policy (2018)
-
Stem cell research, scientific freedom and the commodification concern
EMBO reports (2012)